Compare IMMP & AXIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMMP | AXIL |
|---|---|---|
| Founded | 1987 | 2015 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 35.2M |
| IPO Year | 2012 | 2017 |
| Metric | IMMP | AXIL |
|---|---|---|
| Price | $3.36 | $4.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 30.6K | 20.8K |
| Earning Date | 09-01-2026 | 10-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 230.00 |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $30,847,570.00 |
| Revenue This Year | N/A | $12.27 |
| Revenue Next Year | N/A | $20.93 |
| P/E Ratio | ★ N/A | $90.10 |
| Revenue Growth | N/A | ★ 17.48 |
| 52 Week Low | $0.26 | $4.46 |
| 52 Week High | $5.36 | $9.86 |
| Indicator | IMMP | AXIL |
|---|---|---|
| Relative Strength Index (RSI) | 49.75 | 28.28 |
| Support Level | $3.06 | N/A |
| Resistance Level | $3.55 | $6.35 |
| Average True Range (ATR) | 0.34 | 0.33 |
| MACD | -0.05 | -0.08 |
| Stochastic Oscillator | 41.09 | 15.05 |
Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.
AXIL Brands Inc is engaged in the manufacturing, marketing, sale, and distribution of high tech hearing and audio enhancement and protection products, professional quality hair and skin care products, and the delivery of marketing services. The company has three operating segments: hearing enhancement and protection, hair and skin care and marketing services. The company generates majority of revenue from Hearing enhancement and protection segment. Hearing Enhancement and Protection Products are In-ear protection devices, Over-ear protection devices, and Accessories and others.